microscope-testing

Our Vision & Mission

To Be The Preferred Research Partner In Life Sciences R&D

About Us

Welcome to TheraIndx Lifesciences!

TheraIndx Lifesciences, a leading CRO (Contract Research Organization), is a Preferred Research Partner for the Life Sciences Industry. We offer modular and integrated drug development solutions for pharma and biotech companies across the globe. We participate in R&D programs ranging from hit identification, hit to lead, lead optimization, and preclinical development. Our service offerings encompass in vitro & in vivo biology, medicinal & synthetic chemistry , and translational science across diverse therapeutic areas.

Read More

Hit ID

right-arrow

Hit to
Lead

right-arrow

Lead
Optimization

right-arrow

Preclinical
Development

right-arrow
Our Services

Preclinical Discovery Services

Discovery Services

Modular & integrated discovery biology services for pharma, biotech & allied industries, covering hit identification, hit to lead, lead optimisation & preclinical development.

Allied Biology Services

Microbiology, molecular biology, immunology & cell biology services either as modular or standalone or as a part of integrated drug discovery programs.

Exploratory Toxicology

In vitro & in vivo toxicology services either as modular or standalone, or as a part of integrated discovery programs.

TheraIndx Establishes & Validates Animal Models as per Research Requirements

In vivo Pharmacology Advanced Validated Animal Models with Biomarkers

In the current era of innovation in drug discovery, biotechnology, medical devices or natural products, a key factor in evaluation of a newly designed molecule or product is to obtain robust and quality data from optimally designed experiments.

Read More

Service Models

TheraIndx offers their entire range of discovery services either as modular or stand-alone projects, or as Integrated Programs. Our discovery biology And chemistry capabilities cater to both these models. We also customise our offerings based on your research requirements.

Fee For Service (FFS)
Full Time Equivalent (FTE)
Customised Model
Blogs

Latest Blogs & News

cytotoxicity

Ensuring Safety: Understanding ISO 10993-5 In Vitro Cytotoxicity Testing

Read More
rabbit pyrogenicity

Understanding the Material Mediated Rabbit Pyrogenicity Test

Read More
precision & safety

Ensuring Safety and Efficacy: Implantation Testing for Medical Devices

Read More
novel therapies

Novel Therapies for Diabetic Wound Healing: Insights from Rat Model Studies

Read More
scarring animal model

Bleomycin-Induced Hypertrophic Scarring animal model in Mice

Read More
sensitization & irritation

Ensuring Safety and Compliance: Navigating the ISO 10993-10 Standard

Read More
cytotoxicity

MTT Assay: A Vital Tool for Testing Medical Device Safety

Read More
hemocompatibility

Hemocompatibility Testing for Medical Devices

Read More
rna-technologies

Advances in RNA technologies

Read More
intracutaneous reactivity

Intracutaneous Reactivity Tests for Medical Devices

Read More
microbiome

Explore more about microbiome in human health

Read More
guinea pig maximization test

Importance of the Guinea Pig Maximization Test

Read More
genotoxicity testing

Navigating Genotoxicity Testing in Medical Devices

Read More
ribonucleases targeting

Targeting Ribonucleases with Small Molecules and Bifunctional Molecules

Read More
AEP Inhibitors

Discovery of Orally Available and Brain Penetrant AEP Inhibitors

Read More
molecular strategies

Tuning Molecular Strategies for a Clinically Sound Listening

Read More
FGFR kinase inhibitor

The First Covalent FGFR Kinase Inhibitor in Clinical Use

Read More
mTOR inhibitors optimization

Optimizing mTOR Inhibitors with Property-Based Drug Design

Read More
LSD1 inhibitors

Pyrrolo[2,3-c]pyridines: LSD1 Inhibitors

Read More
GDC 1971 inhibitor

Identification of: GDC 1971 Inhibitors

Read More
thieno pyrimidine derivatives

Identification of Thieno[3,2-d]pyrimidine derivatives

Read More
pharmacokinetics pharmacodynamics

Pharmacokinetic-Pharmacodynamic (PK/PD) of Anti-infective Agents

Read More
evaluating PK/PD properties

Evaluating (PK/PD) Properties of Anti-infective Agents in Preclinical Models of Infection

Read More
organoid cancer models

Organoid Models for Cancer Drug Discovery

Read More
hollow fibre models

Hollow Fiber models in Cancer Drug Discovery

Read More
patient derived xenograft models

Patient Derived Xenograft models in Cancer Drug Discovery

Read More
preclinical animal models

The Mouse Is the Workhorse for Cancer Studies

Read More
biomarkers in cancer

Biomarkers Can Be DNA in a Gene, mRNA, an Enzyme or a Protein

Read More
circRNA in cancer

circRNA in Cancer

Read More

Know more about TheraIndx

Why TheraIndx?

At TheraIndx, we value research. At the heart of our business lies our strength in consulting. We understand the challenges faced by a drug discovery services team. We, therefore, take utmost care to consult, hand hold & suggest the best possible way to achieve optimal results.

Read More

Extensive knowledge & experience in drug discovery

Capability to deliver projects of any size & on time

Deliver high quality preclinical report

Interpretation of biological data

Send message